2004 ORI Research on Research Integrity Conference, University of California, San Diego School of Medicine Paradise Point Resort & Spa November 12-14

2007 ◽  
Vol 6 (2) ◽  
pp. 92-95
Author(s):  
Richard Channick ◽  
Kenneth R. McCurry ◽  
Ronald Pearl ◽  
Stuart Rich

This discussion was moderated by Richard Chan-nick, MD, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California. Panel members included Kenneth R. McCurry, MD, Assistant Professor of Surgery, Division of Cardiothoracic Surgery, Director, Lung and Heart-Lung Transplantation Programs, University of Pittsburgh Department of Surgery, Pittsburgh, Pennsylvania; Ronald Pearl, MD, PhD, Professor and Chair, Anesthesia Department, Stanford University School of Medicine, Stanford, California; and Stuart Rich, MD, Professor of Medicine, Section of Cardiology, Center for Pulmonary Hypertension, University of Chicago, Chicago, Illinois.


1969 ◽  
Vol 17 (3) ◽  
Author(s):  
Bryan A Liang

This issue of the Journal of Commercial Biotechnology includes the papers from the seventh Annual San Diego Health Policy Conference, ‘Public–Private Partnerships in Global Health’, held on 25 March 2011. The San Diego Heath Policy Conference is sponsored by the Institute of Health Law Studies California Western School of Law, in collaboration with the San Diego Center for Patient Safety, University of California, San Diego School of Medicine and the Partnership for Safe Medicines. The event drew both national and international participants with industry representatives, health-care providers, public health officials, law enforcement personnel, attorneys, military representatives, academics and policy experts coming together to assess the role and potential of private–public partnerships in global health activities.


2002 ◽  
Vol 1 (1) ◽  
pp. bmi-7 ◽  
Author(s):  
Lewis J. Rubin ◽  
Robyn Barst ◽  
Nazzareno Galiè

Three physicians addressed key concerns in the treatment of pulmonary hypertension in a discussion that ranged from special considerations in tailoring therapy to the role of new agents dramatically changing the algorithm for managing this disease. The roundtable discussion was moderated by Lewis J. Rubin, MD, Professor of Medicine, University of California, San Diego, School of Medicine, and included Robyn Barst, MD, Professor of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York, and Nazzareno Galiè MD, Professor at the Postgraduate School of Cardiology, University of Bologna, Italy.


Sign in / Sign up

Export Citation Format

Share Document